US FDA Pilot Programs Identified Need For Post-Market Benefit Awareness
Executive Summary
FDA pilot programs conducted before the issuance of a recent final guidance document on benefit-risk factors for post-market decisions found that the agency needed to work on questions used to evaluate the benefits of marketed products, an agency official said.